Skip to main content
. 2021 Jun 28;30:09636897211024942. doi: 10.1177/09636897211024942

Table 3.

Levels of Growth Factors.

Growth Factors Group 1 Group 2 Group 3 P
TGF-β (µg/ml) Min-Max
Mean ± SD
Before procedure 26.8–152.4 22.7–81.4 16.4–108.3 NS
55.7 ± 43.6 38.4 ± 18.3 42.5 ± 22.9
Day 1 20.7–35.6 22.1–80.5 24.5–403.2 <.05
26.9 ± 4.4 38.4 ± 18.4 84.9 ± 48.9
Day 4 24.5–33.5 21.5–79.7 25.9–272.1 <.05
28.5 ± 3.2 37.2 ± 17.9 86 ± 81.5
Day 7 24.8–32.6 21.5–80.1 15.7–281.4 <.05
29 ± 2.6 38.2 ± 11.9 89.2 ± 88.9
VEGF (pg/ml)
Before procedure 1306–3813 1150–3796 1496–3528 NS
2797 ± 716.1 2263 ± 999.4 2842 ± 660.2
Day 1 1576–3748 1470–3788 2024–4679 P < .05
2703 ± 685.9 2270 ± 1006.9 3222 ± 1048
Day 4 1254–3625 1204–3958 2170–5124 P < .05
2524 ± 787.3 2373 ± 938.5 3138 ± 963.5
Day 7 1514–3152 1100–3854 1506.4–5241.6 P < .05
2300 ± 560.2 2314 ± 892.9 3333 ± 1060
KGF (ng/ml)
Before procedure 138.3–172.3 101.1–591.2 130.4–473.9 NS
155.1 ± 11 194.8 ± 140.6 218.4 ± 111.7
Day 1 142.8–182.4 111.5–595.3 106.5–584.6 NS
161.8 ± 11.8 196.8 ± 141.7 216 ± 147.2
Day 4 147.4–180.5 107.5–497 132.6–397.6 NS
165.7 ± 9.9 197.2 ± 141.6 206.1 ± 81.5
Day 7 149–178.5 111.4–597.9 157.7–502.2 P < .05
164.8 ± 9 196.2 ± 142 228.2 ± 73.4
NGF (ng/ml)
Before procedure 1.3–65 0.2–20.4 1.2–15.4  NS
12.2 ± 19.1 8.5 ± 12.4 5.8 ± 5.4
Day 1 0.6–15.8 0.1–22.5 0.1–21.1  NS
7.5 ± 5.2 8.4 ± 12 6.7 ± 6.6
Day 4 2–16.3 1–20.5 2.1–16.8  NS
7.7 ± 5.3 8.3 ± 9.6 12.1 ± 5.5
Day 7 1.5–15.5 0.9–17.1 2.1–24.6 P < .05
7.8 ± 4.8 8.4 ± 12.3 13.7 ± 6.7

P-values following comparison between control groups (Group1 and Group-2) and the study group (Group-3). All values are given as minimum, maximum and mean, NS: not significant, SD: standart deviation.